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Abstract 
Food borne Salmonella Typhimurium is a valid concern for the global pork industry. An attenuated 
oral swine Salmonella Choleraesuis vaccine has proven to be an effective tool for the pre-harvest 
reduction of carrier rates for multiple Salmonella spp. Serum antibody assays are available to 
monitor exposure to wild-type Salmonella infection. This clinical study assessed protection induced 
by an attenuated oral Salmonella Choleraesuis vaccine against challenge infection with S. 
Typhimurium in swine. A serologic antibody assay was concurrently evaluated for its ability to 
differentiate vaccinated pigs from those challenged with Salmonella Typhimurium. Vaccination 
significantly improved clinical scores, pyrexia, and enteric lesion prevalence, while numerically 
improving average daily weight gain, and group body weight variation in comparison to 
unvaccinated/challenged pigs. Vaccination, while protecting pigs against disease, did not generate 
detectable serum antibodies prior to challenge. No vaccinated animals became seropositive prior 
to challenge, indicating that conventional ELISA tests could be used in vaccinated pigs to monitor 
wild-type exposure. Following challenge, there was no detectable difference between 
vaccinated/challenged and non-vaccinated/challenged animals. All strict control pigs remained 
serum antibody negative. These findings support the use of this vaccine to protect swine against S. 
Typhimurium, without confounding pre-harvest Salmonella serologic monitoring programs. 
Introduction 
Salmonella Typhimunum infection in swine reduces growth performance and presents a food 
safely risk to humans. (Flores et a/, 2002. CDC, 2005) A commercial swine vaccine has been 
shown to reduce the carrier rate of pigs infected with various Salmonella spp including S. 
Typhimunum. (Neubauer et a/, 2005. Kolb et a/, 2002. Letellier et a/, 2001 . Baum et a/, 1998.) 
Various pre-slaughter diagnostic tools can aid in the appropriate implementation of vaccination and 
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assessment of the infection status of farms. (Schwartz et al, 2006) Serum antibody tests would be 
most useful if they did not detect antibodies due to vaccination, while still detecting antibody 
generated by infection with wild-type Salmonella. This clinical study evaluated heterologous 
protection and the serum antibody response of pigs vaccinated with attenuated-live S. 
Choleraesuis vaccine, followed by challenge with virulent S. Typhimurium. 
Materials and Methods 
Sixty weaned pigs, approximately 3 weeks of age, were confirmed to be Salmonella serum 
antibody and fecal culture negative. They were blocked by weight and sex and randomly assigned 
to 3 treatment groups (n=20/group, Table 1 ). Group 1 (Infected Control) pigs were non-vaccinated 
and then challenged with virulent Salmonella Typhimurium on Day 43. Group 2 pigs (Vaccinates) 
were vaccinated on Day 0 (Enterisol® SC-54, Boehringer lngelheim Vetmedica, Inc., St Joseph, 
MO, USA) according to the manufacturer's label instructions, and then followed by challenge on 
Day 43. Group 3 (Strict Control) pigs were non-vaccinated and non-challenged. To achieve 
blinding, the person performing observations or necropsies was not present during treatment 
administration. Serum samples were collected from all pigs on Days 0, 7, 14, 21 , 28, 35, 43, 52, 
57, 64 and 70, and tested for anti-Salmonella antibodies (IDEXX HerdChek® Swine Salmonella 
Antibody Test Kit, IDEXX Laboratories Inc., Westbrook, ME, USA). Rectal temperatures were 
measured on Days -2, -1 , 0, daily from Day 1 through 21 , 28, and daily from Day 43 through 58. 
Individual pig weights were recorded on Days -5, 0, 2, 7, 14, 21 , 28, 35, 43, 50, 57, 64, and 71 . 
Clinical observations were recorded on Days -2 through 7, 14, 21 , 28, 35, daily from Day 43 
through 58, 61, 63, 65, 68, and 70 using a qualitative scoring system. On Day 43, virulent 
Salmonella Typhimurium was administered intranasally to Groups 1 and 2 as described in previous 
studies (Neubauer eta/, 2005) On Day 57, half of the pigs in each treatment group were randomly 
selected for euthanasia. The remaining animals were euthanized on Day 71 . Necropsy 
observations were recorded for all animals. Statistical analysis of pyrexia, average daily gain 
(ADG), and clinical score data was performed using Two-sample t-test, and enteric lesion 
statistical analysis used a Fishers Exact Test. Significantly different means were determined using 
the Tukey-Kramer multiple comparisons method with a confidence level of 95% (JMP v5.1, SAS 
Institute, Inc., Cary, NC, USA). 
Table 1 Treatment Groups Events Trmehne 
Day 0 Day43 
Group 1 
- c (Infected control) 
Group 2 v c (vaccinates) 
Group 3 
-(strict control) -
V = Vaccinotton wrth Entensol" SC-54 
C = Chellenge w1th S Typh1munum 
N1 = Necropsy one-hCllf of prgs 111 each trentment group 
N2 = Necropsy remammg prgs m each treatment group 
Results 
Day 57 Oay71 
N, N: 
N, : 
N, N: 
The number of days with elevated rectal temperatures following challenge was significantly less for 
the Vaccinated group than the Infected Control group on 3 of 16 measurement days (P<0.05). 
Mean clinical observation scores were significantly reduced in the Vaccinates compared to the 
Infected Controls on 3 of 20 observation days after challenge (P<0.05). Additionally, Vaccinates 
had numeric improvement of clinical scores compared to Infected Controls on 9 of 20 days, 
equivalent clinical scores on 7 of 20 days, and numerically higher clinical scores on only a single 
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day. Enteric lesion prevalence at necropsy was significantly reduced in Vaccinates compared to 
the Infected Controls with 3 of 20, and 9 of 19 pigs respectively showing lesions suggestive of S. 
Typhimurium infection (P<0.05). Vaccinates tended to have reduced post-challenge variability in 
average daily weight gain (ADG) (Day 43 through 57) compared to Infected Control pigs, with 
coefficient of variation (CV) values of 28.1% and 31.4% respectively. This trend continued from 
Day 57 through Day 71 with CV values of 11 .3% and 16.6% respectively (Table 2). Only 1 of 140 
serum samples from Vaccinates was ELISA positive from Day 0 through Day 43 (post-
vaccination/pre-challenge). This singleton reactor was interpreted as a probable false positive 
consistent with published diagnostic kit specificity performance. (Rossi, Ballagi, 2006) 
Seroconversion of all Vaccinates and Infected Controls was observed by 9 days following 
challenge infection (study Day 52). Internal biosecurity measures utilized during the study were 
validated by the lack of Salmonella seroconversion in all Strict Control pigs (Figure 1). 
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Following S . Typhimurium challenge, pigs vaccinated with Enterisol® SC-54 had significant 
reductions 1n pyrexia, clinrcal signs, enteric lesron prevalence and significant improvement in ADG 
from Day 43 through 57 Vaccinates also demonstrated numeric improvements in ADG from Day 
57 through 71 and reduced group weight variation compared to nonvaccinated pigs. These findings 
confirm the ability of this vaccrne to provide heterologous protection. Vaccination did not result in a 
significant incidence of seroconversion. However, all pigs challenged with virulent Salmonella 
Typhrmunum, regardless of vaccination status, seroconverted within 9 days of challenge. Lack of 
seroconversion in response to vaccination rndicates that this assay IS not suitable as a vaccination 
compliance tool or as an mdicator of protective immunity. Rapid seroconversion following infection 
demonstrates the ability of th1s assay to differentiate Salmonella-exposed pigs from non-exposed 
pigs regardless of vaccination status. The findings from this study support the use of this vaccine to 
clinically protect pigs from heterologous Salmonella infection, while preserving the ability to use the 
serologic tool to assess exposure status to wild-type Salmonella infection. Other studies have 
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demonstrated the abthty of thts vacctne to reduce the carrier rate of multiple Salmonella spp 
(Neubauer eta/, 2005. Kolb eta/, 2002 Letellier eta/, 2001 Baum eta/, 1998.), thereby potentially 
1mprov1ng the food safety profile of pork from vaccinated pigs. The collective effects reported from 
this and other referenced studtes support broader use of this vaccine, both as a climcal and 
productivity tool in swine production, as well as a potenttal pre-harvest food safety Improvement 
measure 
Conclusions 
The results of this clinical trial indicate 
• Vaccmat1on of sw1ne w1th Entensol SC-54 provtdes heterologous protect1on agatnst 
Salmonella Typhtmunum infectton. a common cause of food borne Salmonella tllness 
• The IDEXX HerdChek Swtne Salmonella ELISA does not detect a serologtc response to 
Entensol SC-54 vaccmatton, but wtll detect antibod1es to Wild-type S. Typh1murium 
mfecllon regardless of vacc1nat1on status This allows for vaccination w1thout comprom1s1ng 
serologiC Salmonella momtonng programs usmg th1s assay 
344 po• k 007 V ron (ll1ly) 
